4.965

3.12% -0.16

Journey Medical Corp (DERM)

Overview News Price History Option Chain Financials Discussions Forecast

Journey Medical Corp stock is traded at $4.965, with a volume of 186.20K. It is down -3.12% in the last 24 hours and down -31.89% over the past month. Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Previous Close:

$5.125

Open:

$5.15

24h Volume:

186.20K

Relative Volume:

0.95

Market Cap:

$140.13M

Revenue:

$61.86M

Net Income/Loss:

$-11.43M

P/E Ratio:

-10.31

EPS:

-0.4818

Net Cash Flow:

$-12.52M

1W Performance:

-21.32%

1M Performance:

-31.89%

6M Performance:

-3.97%

1Y Performance:

-32.91%

1-Day Range:

$4.78

$5.18

1-Week Range:

$4.78

$6.435

52-Week Range:

$4.31

$9.555

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1052)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2026-11-11

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	4.965	140.13M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Initiated	H.C. Wainwright	Buy
Jul-30-25	Resumed	B. Riley Securities	Buy
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

Oct 09, 2026

An investment adviser reports passive ownership of 2.45M shares in Journey Medical (DERM). - Stock Titan

Oct 09, 2026

Oct 01, 2026

Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com India

Oct 01, 2026

Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com UK

Oct 01, 2026

Sep 21, 2026

7 Best Travel & Tourism Stocks for 2026 and How to Invest - The Motley Fool

Sep 21, 2026

Are Options Traders Betting on a Big Move in Journey Medical Stock? - Zacks Investment Research

Sep 21, 2026

Sep 11, 2026

Journey Medical Corporation $DERM Shares Sold by Opaleye Management Inc. - marketbeat.com

Sep 11, 2026

Sep 08, 2026

Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo Finance

Sep 08, 2026

Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com

Sep 08, 2026

Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan

Sep 08, 2026

Nine FDA-approved skin drugs are marketed by Journey Medical. Its CEO will join two investor events. - Stock Titan

Sep 08, 2026

Sep 07, 2026

DERM 8-K FilingsJourney Medical Corporation SEC 8-K - Stock Titan

Sep 07, 2026

Sep 03, 2026